GlobalOrthobiologics Market was valued US$ XX Bn in 2019 and is expected to reachXX Bn by 2027, at a CAGR of XX % duringa forecast period.

GlobalOrthobiologics Market was valued US$ XX Bn in 2019 and is expected to reachXX  Bn by 2027, at a CAGR of XX % duringa forecast period.

 

The report includes the analysis of impact of COVID-19lock-down on the revenue of market leaders, followers, and disrupters. Sincelock down was implemented differently in different regions and countries,impact of same is also different by regions and segments. The report hascovered the current short term and long term impact on the market, same willhelp decision makers to prepare the outline for short term and long termstrategies for companies by region.

 

 

 

To know about the Research Methodology:-Request Free SampleReport

 

Orthobiologics refer to biologics and cellular therapies in orthopedicsmade of a range of products such as recombinant growth factors, bone voidfillers, stem cells, and grafts. Orthobiologics are also called regenerativecellular therapies.

 

Increased incidences of sports injury, road accidents, andosteoarthritis, growing obese and geriatric population, and consumer preferencetowards the adoption of minimally invasive surgeries are expected to drive theglobal orthobiologics market. Orthopedic disorders caused by accident andtrauma are increased exponentially, which will further boost the growth of theorthobiologics market.

 

Spinal fusion is a primary application in the globalorthobiologics market owing to the growing usage of demineralized bonematrices, bone morphogenetic proteins, and autografts and allografts in spinalfusion surgeries. Spinal fusion has the capability to speed up the bone healingprocess and it also offers high bone stability, smoothing long-term improvementof spinal disorders. It also helps to fast stimulation of cells to empower boneformation and avoids hospital stays and pedestrian visits.

 

Viscosupplementation business segment is estimated to leadthe global orthobiologics market. The leading position in the market iscredited to the increasing adoption of orthobiologics owing to the extensiverange availability and unique adoption in diseases like Osteoarthritis and hipdegenerative joint disease. Viscosupplementation offers benefits like enhancedknee movement, pain reduction, less-invasive, and fewer side effects.

 

North America is expected to dominate the globalorthobiologics market during the forecast period. The dominant position in themarket is attributed to the growing incidences of spinal disorders, growing thegeriatric and obese population, rising preference for nominally invasiveprocedures, and growing physician and patient awareness about innovativetreatment procedures and technologies. In this region, the United States isexpected to hold the US XX Mn market share in the orthobiologics market.Furthermore, Asia Pacific is expected to grow at a XX % rate of CAGR in theglobal orthobiologics market during the forecast period. The governmentinitiatives to an expansion of the healthcare infrastructure, the boomingmedical tourism industry in developing countries like India, Thailand, andIndonesia are expected to share significant growth in the orthobiologics marketin this region.

 

The objective of the report is to present a comprehensiveassessment of the market and contains thoughtful insights, facts, historicaldata, industry-validated market data and projections with a suitable set of assumptionsand methodology. The report also helps in understanding dynamics, structure byanalysing the market segments and, project the global orthobiologics market.The report also provides a clear representation of competitive analysis of keyplayers by product, price, financial position, product portfolio, growthstrategies, and regional presence in the global orthobiologics market. Thereport also provides PEST analysis, PORTER’s analysis, SWOT analysis to addressthe question of shareholders in arranging the efforts and investment in thenear future to a particular market segment.

Scope of the Report for Global Orthobiologics Market:Inquire before buying

 

Global Orthobiologics Market, By Product

 

• Viscosupplementation Products

• Demineralized Bone Matrix

• Synthetic Orthobiologics

• Bone Morphogenetic Protein

• Allografts

• Plasma-Rich Protein

• Bone Marrow Aspirate Concentrate

Global Orthobiologics Market, By Type

 

• Knee

• Ankle

• Hip

• Wrist & Shoulder

• Spine

• Others

GlobalOrthobiologics Market, By Application

 

• Osteoarthritis and Degenerative Arthritis

• Spinal Fusion

• Fracture Recovery

• Soft Tissue Injuries

• Maxillofacial and Dental Applications

Global Orthobiologics Market, By End User

 

• Hospitals, Orthopedic Clinics, and Ambulatory Care Centers

• Research and Academic Institutes

• Dental Clinics and Facilities

Global Orthobiologics Market, By Region

 

• North America

• Europe

• Asia Pacific

• Middle East & Africa

• South America

Key players, Global Orthobiologics Market

 

• Stryker Corporation

• Depuy Synthes

• Xtant Medical Holdings, Inc.

• Zimmer Biomet Holdings, Inc.,

• Wright Medical Group, Inc.,

• Integra Life Sciences Holdings Corporation

• Arthrex, Inc.

• Medtronic PLC.

• Exactec Inc.

• Orthofix International N.V.

• Medline Industries, Inc.

• Globus Medical, Inc.,

• Harvest Technologies Corporation

• NuVasive Inc.

• K2M Group Holdings, Inc.

• RTI Surgical, Inc.

• Seaspine Holdings Corporation

• Korus Biosciences AG

• Xtant Medical

• Bioventus LLC

 For More InformationVist : https://www.maximizemarketresearch.com/market-report/global-orthobiologics-market/29638/

Report Is Submitted By : Maximize Market Research Company 

 

 

 

 

 

 


Customization of the report:

 

 

 

 

 

 

Maximize Market Research of reports as per your demand. Thisreport can be personalized to meet your requirements. Get in touch with us andour sales team will guarantee provide you to get a report that suits yournecessities.

 

 

 

 

About Maximize Market Research:

 

 

 

Maximize Market Research provides B2B and B2C research on20,000 high growth emerging opportunities & technologies as well as threatsto the companies across the Healthcare, Pharmaceuticals, Electronics & C

ommunications, Internet of Things, Food and Beverages,Aerospace and Defense and other manufacturing sectors.